𝐆𝐞𝐨𝐬𝐩𝐚𝐭𝐢𝐚𝐥 𝐀𝐧𝐚𝐥𝐲𝐭𝐢𝐜𝐬 : Advancements in Artificial Intelligence, Machine Learning, and Big Data Technologies to Drive Industry Growth

Geospatial analytics is the process of gathering geographic data and processing it for industrial use. Geospatial data is time-based data in correlation with the specific location on the earth’s surface. It can provide insights into relationships between variables and reveal patterns and trends. Geospatial analytics is used to add timing and location to traditional data types and build data visualizations. These visualizations include maps, graphs, statistics, and cartograms that show historical changes and current shifts. This data helps to make predictions faster, easier, and accurate decisions.

 

The geospatial analytics market is driven by the growing use of artificial intelligence and machine learning-based GIS solutions. The use of AI-based GIS solutions is rapidly advancing the data gathering and cleansing process. Different industries are using smart predictive analytics of AI to improve their predictive accuracy. In addition, advancement in big data analytics provides benefits, such as data accumulation from multiple sources, including earth observation, GIS, GNSS & positioning, and 3D scanning using drones and UAVs, enabling real-time forecasting and business monitoring and helps identify crucial points in large data sets. Furthermore, increasing utilization of IoT in smart homes and smart cities is further influencing the demand for geospatial analytics. Cloud computing is easing accessing and uploading a large amount of geospatial data on the cloud. This helps simplify data revival and retrieval and helps in assisting data management.

 

However, some of the key factors hindering the growth of the market are the easy access to public geo-information via web applications, which is a major concern for data privacy and high set-up and operating cost, including workforce and infrastructure.

 

According to a new market research report titled “Geospatial Analytics Market by Technology (Earth Observation, GIS, GNSS, 3D Scanning), Component, Deployment Mode, Organization Size, Application (Surveying, Urban Planning), and End User (Healthcare, Transportation, Telecom)—Global Forecast to 2028”, published by Meticulous Research®, the geospatial analytics market is expected to grow at a CAGR of 17.6% from 2021 to 2028 to reach $256 billion by 2028.

 

Download Research PDF with TOC @ https://www.meticulousresearch.com/download-sample-report/cp_id=5161?utm_source=PDF&utm_medium=Social&utm_campaign=Product&utm_content=28-12-2021

 

The Impact of COVID-19 on the Geospatial Analytics Market

The spread of COVID-19 has had an unprecedented impact on public health and industrial structures, accelerating social reforms in several areas. Though the nature of the macro challenges, such as disrupted supply chains, decentralized workforce, and the provision of safe and healthy employee workspaces, are different than in past recessions, market players must deal with these monumental challenges.

The spread of COVID-19 has had a severe impact on the performance of several industries and economies across the globe. Governments have forced lockdowns worldwide, shutting down manufacturing plants and halting import-export operations. As a result, several industries have stopped their ongoing production operations, disrupting supply chains and affecting the demand-supply balance. Most industries have been experiencing severe challenges and companies are restructuring their business strategies to improve recovery and revenue generation.

 

The lockdown has negatively impacted the manufacturing, logistics, transportation, retail, education, mining, telecom, oil & gas, and utility industries. However, the adoption of geospatial analytics is on the rise in the healthcare sector for tackling the COVID-19 pandemic. Healthcare consultants, government decision-makers, and institutions working at the ground level have collaborated to generate real-time data on COVID-infected patients and share geographical information of the COVID-19 prone area to spread awareness among the local public and curb the spread of the virus. For instance, in June 2021, Novartis International AG collaborated with Hewlett Packard Enterprise (U.S.) to accelerate the use of health data sources and advance the application of artificial intelligence, machine learning, and geospatial analytics, expanding access to technology in remote and underserved locations.

Overall, COVID-19 has impacted the adoption of geospatial technologies severely. However, the adoption of geospatial technologies grew in the healthcare sector.

 

Visit on Geospatial Analytics Market Research Report:   https://www.meticulousresearch.com/product/geospatial-analytics-market-5161?utm_source=PDF&utm_medium=Social&utm_campaign=Product&utm_content=28-12-2021

 

To provide efficient analysis, Meticulous Research® has segmented this market based on technology (GNSS, GIS, Earth Observation, and 3D Scanning), component (software and services), deployment mode (cloud and on-premise);  organization size (large enterprises, small & medium enterprises); application (surveying, military & border security, disaster management, marketing management, urban planning, public safety, and asset management); end-user (natural resources, security & defense, BFSI, media & entertainment, healthcare, AEC, education, telecom, manufacturing, oil & gas, retail, transportation & logistics, and utilities); and by geography (North America, Asia-Pacific, Europe, Latin America, and the Middle East & Africa).

 

Based on technology, the geospatial analytics market is segmented into GNSS, GIS, earth observation, and 3D scanning. In 2021, the GNSS & positioning segment is estimated to account for the largest share of the overall geospatial analytics market. The large share of this segment is mainly attributed to the growing adoption of tracking devices based on GNSS & positioning technologies, such as GPS in the transportation & logistics sector. However, the 3D scanning segment is estimated to be the fastest-growing segment during the forecast period.

Based on component, the geospatial analytics market is segmented as software and services. In 2021, the services segment is estimated to account for the largest share of the global geospatial analytics market. The large share of the segment is mainly attributed to the growing demand for training & geo-consultation services.

Based on application, the surveying segment is expected to account for the largest share of the overall geospatial analytics market in 2021. The large share of this segment is mainly attributed to the growing adoption of GIS technology for security & surveillance. The use of surveying in smart cities across the globe has influenced the use of geospatial analytics for surveying in recent years.

 

Based on deployment mode, the cloud-based segment is estimated to account for the largest share of the overall geospatial analytics market in 2021. The advantages of cloud-based offerings include scalable computing, storage of large datasets, big data computation, and the ability to surge resources during critical events such as disasters has further helped this segment to grow with the fastest CAGR during the forecast period.

  

Check Discount @ https://www.meticulousresearch.com/request-discount/cp_id=5161?utm_source=PDF&utm_medium=Social&utm_campaign=Product&utm_content=28-12-2021

 

Based on organization size, the large enterprises segment is estimated to account for the largest share of the overall geospatial analytics market in 2021. However, SMEs are estimated to grow with the fastest CAGR during the forecast period. Extensive support from governments and major investors, an increasing need to achieve a significant position in the industry, and a growing focus on gaining a maximum number of customers to their portfolio are some of the factors driving the segment growth.

 

Based on end user, the transportation & logistics segment is expected to account for the largest share of the overall geospatial analytics market in 2021. The large share of this segment is mainly attributed to the growing adoption of geospatial technology-based on GNSS & positioning platforms, such as GPS in the transportation & logistics sector. In addition, the growing investment in autonomous vehicles, self-driving cars, and connected cars is further estimated to drive the growth of this segment at the highest CAGR during the forecast period.

Geographically, the global geospatial analytics market is segmented into North America, Asia-Pacific, Europe, Latin America, and the Middle East & Africa. In 2021, North America is estimated to account for the largest share of the global geospatial analytics market. The large share of this region is attributed to the technological advancements in big data, AI & ML; the growing number of on-road connected vehicles and self-driving cars; the presence of several major market players in the region; and the growing significance of geospatial analytics applications in the transportation & logistics sector. However, the Asia-Pacific region is expected to account for the fastest growth during the forecast period. Proliferation in the number of smart cities projects, the advent of 5G technology and the development of associated infrastructure, and the growing significance of smart utilities are driving the growth of the APAC geospatial analytics market.

 

Some of the key players operating in the in the global geospatial analytics market are ESRI (U.S.), Oracle Corporation (U.S.), Alteryx, Inc. (U.S.), Fugro N.V. (Netherlands), Hexagon AB (Sweden), RMSI Pvt. Ltd., India (India), SAP SE (Germany), Trimble Inc. (U.S.), L3Harris Technologies, Inc. (U.S.), General Electric Company (U.S.), TomTom N.V. (Netherlands), Autodesk, Inc. (U.S.), Google LLC (U.S.), Atkins (U.K.), AAM Pty Ltd. (Australia), Orbital Insight (U.S.), Cyient Limited (India), Precisely (U.S.), HERE (Netherlands), and CARTO (U.S.), among others.

 

TOP 10 COMPNIES IN GEOSPATIAL ANALYTICS MARKET

 

Scope of the Report

Geospatial Analytics Market, by Technology

• Earth Observation
• GIS
• GNSS & Positioning
• 3D Scanning

Geospatial Analytics Market, by Component

• Software

• • Mapping
  • Spatial Analysis
  • Geo-visualization
  • Data Management

• Services

• • System Integration
  • Training & Geo-consultation
  • Support & Maintenance

Geospatial Analytics Market, by Deployment Mode

• Cloud
• On-premise

Geospatial Analytics Market, by Organization Size

• SMEs
• Large Enterprises

Geospatial Analytics Market, by Application

• Surveying
• Military/Border Security
• Disaster Management
• Marketing Management
• Urban Planning
• Public Safety
• Asset Management

Geospatial Analytics Market, by End User

• Natural Resources
  • Agriculture
  • Forestry
  • Fishery
  • Mining
• Security & Defense
• BFSI
• Media & Entertainment
• Healthcare
• Architecture, Engineering & Construction
• Education
• Telecom
• Manufacturing
• Oil & Gas
• Retail
• Transportation & Logistics
• Utilities

 

Geospatial Analytics Market, by Geography:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia-Pacific
• Latin America
• Middle East & Africa

Buy Now @ https://www.meticulousresearch.com/BuyNowToCheckout/1389?utm_source=PDF&utm_medium=Social&utm_campaign=Product&utm_content=28-12-2021

 

Related Research

 

Unmanned Aerial Vehicles (UAVs) Market by Component (Hardware, Software), Class (Mini UAVs, Micro UAVs), End User (Military, Commercial, Agriculture), Type (Fixed Wing, Rotary-Wing), Capacity, and Mode of Operation—Global Forecast to 2027

Real-world evidence (RWE) offer the potential to help inform and potentially improve Healthcare Decisions.

 

Real-world evidence (RWE) is clinical evidence gathered via real-world data (RWD) analysis on a medical product’s use and potential benefits or risks. RWE can be produced through various study designs or analyses, including but not limited to randomized trials, large simple trials, pragmatic trials, and observational studies (prospective or retrospective). For example, the role of RWE in drug development is expanding as RWE studies are significantly less costly and time-consuming than RCTs, providing easier access to long-term effectiveness data and helping overcome some of the feasibility barriers of running RCTs. RWE is regularly utilized in the drug development & approval process to inform aspects of drug development, such as the natural history and epidemiology of a disease, and to provide data on treatment pathways and comparator interventions in clinical practice.

According to a new market research report titled “RWE Solutions Market by Component (Datasets [Clinical, Claims, Pharmacy, integrated], Services), Application (Market Access, Oncology, Neurology, Post Market Surveillance), End User (Pharma Companies, Providers) — Global Forecast to 2028”, published by Meticulous Research^®, the real-world evidence solutions market is expected to grow at a CAGR of 11.8% from 2021–2028 to reach $4.4 billion by 2028.

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=4954?utm_source=Blog&utm_medium=Social&utm_campaign=Product&utm_content=22-12-2021

Real-world evidence (RWE) is clinical evidence gathered via Real World Data (RWD) analysis on the use and potential benefits or risks of a medical product. RWE can be produced through various study designs or analyses, including but not limited to randomized trials, large simple trials, pragmatic trials, and observational studies (prospective or retrospective). RWE has several applications, including drug development life cycles, shortening development timelines, reducing the costs of clinical trials, and improving the probability of technical and regulatory success. The growth of this market is primarily driven by key factors such as the rapid growth of large data in healthcare, the shift from volume to value-based care, and the rising focus towards personalized healthcare.

Impact of COVID-19 on RWE Solutions Market

The key players operating in the RWE solutions market experienced an initial market shrinkage due to uncertainties associated with the impact of the COVID-19 pandemic. The market shrinkage was mainly due to significant restrictions on travel in many countries, shifting of resources on COVID-19 treatments in healthcare settings, and limited access to hospitals. These factors affected the amount of real-world data generated globally.

However, after the initial shrinkage, real-world evidence (RWE) is set to become the most influential emerging technology to fight against the COVID-19 outbreak. Real-world evidence solutions can provide valuable insights to better understand, monitor, and prepare for the challenges caused by the COVID-19 pandemic. RWD has been used increasingly to map the progression of the disease and to discover vaccines and immediate treatments. Thus, the effectiveness of the use of RWD made a significant impact during the pandemic and continues to play a significant role in the treatment of infected patients.

Quick Buy – RWE Solutions Market Research Report:    https://www.meticulousresearch.com/BuyNowToCheckout/751?utm_source=Blog&utm_medium=Social&utm_campaign=Product&utm_content=22-12-2021

RWE Solutions Market: Future Outlook

The RWE Solutions Market is segmented by component (datasets and consulting services), application (market access & reimbursement/coverage decisions, drug development & approvals, post market surveillance, medical device development & approvals, and other applications), end user (pharmaceutical, biotechnology, and medical device companies, healthcare payers, healthcare providers, and other end users), and geography (North America, Asia-Pacific, Europe, Latin America, and the Middle East & Africa).

Based on component, the datasets segment is estimated to account for a larger share of the overall RWE solutions market in 2021. The large share of this segment is mainly attributed to the growing amount of medical data generated in hospitals and the increasing dependence of outcome-based studies on real-world data. EHRs are the most commonly used form of healthcare database that helps in conducting outcome-based studies. EHR data is playing an increasingly vital role in collecting and generating actionable information at the FDA. Governments across the world are undertaking initiatives to increase the adoption of EHR/EMR data. For instance, in September 2020, to digitalize the entire healthcare ecosystem of India, the Ministry of Health and Family Welfare (MoHFW) released a draft policy termed the Health Data Management Policy. However, the consulting services segment is expected to witness the fastest growth rate during the forecast period. Real-world evidence consulting service providers make use of robust real-world datasets generated by conducting prospective/observational studies to offer customized consulting services to generate fit-for-purpose data and insights for their stakeholders instead of providing terabytes of data.

Based on application, the market access & reimbursement/coverage decisions segment is estimated to account for the largest share of the RWE solutions market in 2021. The pharmaceutical, biotech, and medical device industries face unprecedented challenges due to the global economic crisis, COVID-19 pandemic, and concerns about escalating healthcare costs. Due to rising therapy costs, healthcare payers are increasingly focused on evidence of clinical value for making decisions associated with providing coverage. RWE helps provide a means for demonstrating value, ranging from confirming randomized trial benefits in real-world populations to a fuller characterization of resource impacts. RWE is being increasingly considered by both industry and payers. Payers use the data to support coverage decisions, develop guidelines and decision support tools for use in clinical practice, generate estimates of the potential population they cover that could require the treatment, and estimate potential costs and cost offsets. However, the drug development & approvals segment is expected to witness the fastest growth rate during the forecast period.

To gain more insights into the market with a detailed table of content and figures, click here:  https://www.meticulousresearch.com/product/Real-World-Evidence-Solutions-Market-4954?utm_source=Blog&utm_medium=Social&utm_campaign=Product&utm_content=22-12-2021

Based on end user, the pharmaceutical, biotechnology, & medical device companies segment is expected to witness the fastest growth rate during the forecast period. Rising pharmaceutical R&D spending is the major factor attributed to the growth of this segment. The cost of developing a new drug was more than $2,600 million in 2020 compared to $802 million in 2003. This increase in drug development costs reflects various technical, regulatory, and economic challenges pharmaceutical R&D pipelines face. The global R&D spending in 2021 surged by 7.0% ($212 billion) compared to 2020. Real-world evidence helps in understanding real-life clinical practices and actual health outcomes of drugs. It also helps generate broader scientific evidence and commercial insights, valuable for the pharmaceutical industry.

Geographically, North America is estimated to command the largest share of the global RWE solutions market in 2021, followed by Asia-Pacific, Europe, Latin America, and the Middle East & Africa. However, Asia-Pacific region is expected to be the fastest-growing regional market due to growing demand from payers for data that defines the value and effectiveness of medicines, growing demand in conducting real-world studies in drug R&D, and increasing government interest in using real-world studies for regulatory decision-making.

Key companies operating in the global RWE solutions market are IQVIA Holdings Inc. (U.S.), ICON plc (Ireland), PPD, Inc. (U.S.), SYNEOS HEALTH, INC. (U.S.), CLARIVATE PLC (U.S.), Medpace Holdings Inc. (U.S.), Symphony Innovation, LLC (U.S.), Clinigen Group plc (U.K.), Cognizant Technology Solutions Corporation (U.S.), IBM Corporation (U.S.), Oracle Corporation (U.S.), PAREXEL International Corporation (U.S.), PerkinElmer, Inc. (U.S.), SAS Institute Inc. (U.S.), UnitedHealth Group Incorporated (U.S.), and Flatiron Health (U.S.) among others.

TOP 10 COMPANIES IN REAL WORLD EVIDENCE (RWE)SOLUTIONS MARKET

Scope of the Report

RWE Solutions Market, by Component

• Datasets
• Disparate Datasets
• EMR/EHR/Clinical Data
• Claims & Billing Data
• Pharmacy Data
• Product/Disease Registries Data
• Other Disparate Datasets
• Integrated Datasets
• Consulting & Analytics

(Note: Other Disparate Datasets include data generated from mobile devices, wearable devices, and social media)

RWE Solutions Market, by Application

• Market Access & Reimbursement/Coverage Decisions
• Drug Development & Approvals
• Oncology
• Neurology
• Immunology
• Cardiovascular Diseases
• Other Therapeutic Areas
• Post Market Surveillance
• Medical Device Development & Approvals
• Other Applications

(Note: Other Therapeutic Areas include infectious diseases, musculoskeletal disorders, dermatological diseases, and respiratory diseases, Other Applications include regulatory and clinical decision-making)

RWE Solutions Market, by End User

• Pharmaceutical, Biotechnology, and Medical Device Companies
• Healthcare Payers
• Healthcare Providers
• Other End Users

(Note: Other end users include academic research institutions, patient advocacy groups, regulators, and health technology assessment agencies)

RWE Solutions Market, by Geography

• North America
• U.S.
• Canada
• Europe
• Germany
• France
• U.K.
• Italy
• Spain
• Rest of Europe (RoE)   
• Asia-Pacific (APAC)
• Japan
• China
• India
• South Korea
• Taiwan
• Singapore
• Rest of APAC (RoAPAC)
• Latin America
• Middle East & Africa

Download Free Sample Report Now @  https://www.meticulousresearch.com/download-sample-report/cp_id=4954?utm_source=Blog&utm_medium=Social&utm_campaign=Product&utm_content=22-12-2021

Related Reports:

Healthcare IT Market by Product (EMR, mHealth, PHM, RIS, PACS, RCM, Healthcare Analytics, Telehealth, SCM, HIE), Component (Software, Service), Delivery Mode (Web, Cloud) and End User (Hospital, Payer, Pharmacy, Ambulatory, Homecare)—Global Forecast to 2027

Next-generation Sequencing Services Market by Type (Targeted Sequencing, Exome, RNA-Seq, ChIP Sequencing), Technology (Sequencing by Synthesis, Nanopore, SMRT), Application (Clinical Diagnosis, Biomarker Discovery), & End User - Forecast to 2028

Digital Diabetes Market by Product (SMBG, CGM, Smart Insulin Pump, Smart Insulin Pens, Software, Apps), End User (Home Care, Hospitals and Clinics), and Geography - Global Forecast to 2025

𝐑𝐞𝐚𝐥-𝐖𝐨𝐫𝐥𝐝 𝐄𝐯𝐢𝐝𝐞𝐧𝐜𝐞 (𝐑𝐖𝐄) offer the potential to help inform and potentially improve 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗗𝗲𝗰𝗶𝘀𝗶𝗼𝗻𝘀.

 Real-world evidence (RWE) is clinical evidence gathered via real-world data (RWD) analysis on a medical product’s use and potential benefits or risks. RWE can be produced through various study designs or analyses, including but not limited to randomized trials, large simple trials, pragmatic trials, and observational studies (prospective or retrospective). For example, the role of RWE in drug development is expanding as RWE studies are significantly less costly and time-consuming than RCTs, providing easier access to long-term effectiveness data and helping overcome some of the feasibility barriers of running RCTs. RWE is regularly utilized in the drug development & approval process to inform aspects of drug development, such as the natural history and epidemiology of a disease, and to provide data on treatment pathways and comparator interventions in clinical practice.

According to a new market research report titled “RWE Solutions Market by Component (Datasets [Clinical, Claims, Pharmacy, Integrated], Services), Application (Market Access, Oncology, Neurology, Post Market Surveillance), End User (Pharma Companies, Providers) — Global Forecast to 2028”, published by Meticulous Research^®, the real-world evidence solutions market is expected to grow at a CAGR of 11.8% from 2021–2028 to reach $4.4 billion by 2028.

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=4954?utm_source=Article&utm_medium=Social&utm_campaign=Product&utm_content=15-12-2021

Real-world evidence (RWE) is clinical evidence gathered via Real World Data (RWD) analysis on the use and potential benefits or risks of a medical product. RWE can be produced through various study designs or analyses, including but not limited to randomized trials, large simple trials, pragmatic trials, and observational studies (prospective or retrospective). RWE has several applications, including drug development life cycles, shortening development timelines, reducing the costs of clinical trials, and improving the probability of technical and regulatory success. The growth of this market is primarily driven by key factors such as the rapid growth of large data in healthcare, the shift from volume to value-based care, and the rising focus towards personalized healthcare.

Impact of COVID-19 on RWE Solutions Market

The key players operating in the RWE solutions market experienced an initial market shrinkage due to uncertainties associated with the impact of the COVID-19 pandemic. The market shrinkage was mainly due to significant restrictions on travel in many countries, shifting of resources on COVID-19 treatments in healthcare settings, and limited access to hospitals. These factors affected the amount of real-world data generated globally.

However, after the initial shrinkage, real-world evidence (RWE) is set to become the most influential emerging technology to fight against the COVID-19 outbreak. Real-world evidence solutions can provide valuable insights to better understand, monitor, and prepare for the challenges caused by the COVID-19 pandemic. RWD has been used increasingly to map the progression of the disease and to discover vaccines and immediate treatments. Thus, the effectiveness of the use of RWD made a significant impact during the pandemic and continues to play a significant role in the treatment of infected patients.

Quick Buy – RWE Solutions Market Research Report: https://www.meticulousresearch.com/Checkout/98458809?utm_source=Article&utm_medium=Social&utm_campaign=Product&utm_content=15-12-2021

RWE Solutions Market: Future Outlook

The RWE Solutions Market is segmented by component (datasets and consulting services), application (market access & reimbursement/coverage decisions, drug development & approvals, post market surveillance, medical device development & approvals, and other applications), end user (pharmaceutical, biotechnology, and medical device companies, healthcare payers, healthcare providers, and other end users), and geography (North America, Asia-Pacific, Europe, Latin America, and the Middle East & Africa).

Based on component, the datasets segment is estimated to account for a larger share of the overall RWE solutions market in 2021. The large share of this segment is mainly attributed to the growing amount of medical data generated in hospitals and the increasing dependence of outcome-based studies on real-world data. EHRs are the most commonly used form of healthcare database that helps in conducting outcome-based studies. EHR data is playing an increasingly vital role in collecting and generating actionable information at the FDA. Governments across the world are undertaking initiatives to increase the adoption of EHR/EMR data. For instance, in September 2020, to digitalize the entire healthcare ecosystem of India, the Ministry of Health and Family Welfare (MoHFW) released a draft policy termed the Health Data Management Policy. However, the consulting services segment is expected to witness the fastest growth rate during the forecast period. Real-world evidence consulting service providers make use of robust real-world datasets generated by conducting prospective/observational studies to offer customized consulting services to generate fit-for-purpose data and insights for their stakeholders instead of providing terabytes of data.

Based on application, the market access & reimbursement/coverage decisions segment is estimated to account for the largest share of the RWE solutions market in 2021. The pharmaceutical, biotech, and medical device industries face unprecedented challenges due to the global economic crisis, COVID-19 pandemic, and concerns about escalating healthcare costs. Due to rising therapy costs, healthcare payers are increasingly focused on evidence of clinical value for making decisions associated with providing coverage. RWE helps provide a means for demonstrating value, ranging from confirming randomized trial benefits in real-world populations to a fuller characterization of resource impacts. RWE is being increasingly considered by both industry and payers. Payers use the data to support coverage decisions, develop guidelines and decision support tools for use in clinical practice, generate estimates of the potential population they cover that could require the treatment, and estimate potential costs and cost offsets. However, the drug development & approvals segment is expected to witness the fastest growth rate during the forecast period.

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/Real-World-Evidence-Solutions-Market-4954?utm_source=Article&utm_medium=Social&utm_campaign=Product&utm_content=15-12-2021

Based on end user, the pharmaceutical, biotechnology, & medical device companies segment is expected to witness the fastest growth rate during the forecast period. Rising pharmaceutical R&D spending is the major factor attributed to the growth of this segment. The cost of developing a new drug was more than $2,600 million in 2020 compared to $802 million in 2003. This increase in drug development costs reflects various technical, regulatory, and economic challenges pharmaceutical R&D pipelines face. The global R&D spending in 2021 surged by 7.0% ($212 billion) compared to 2020. Real-world evidence helps in understanding real-life clinical practices and actual health outcomes of drugs. It also helps generate broader scientific evidence and commercial insights, valuable for the pharmaceutical industry.

Geographically, North America is estimated to command the largest share of the global RWE solutions market in 2021, followed by Asia-Pacific, Europe, Latin America, and the Middle East & Africa. However, Asia-Pacific region is expected to be the fastest-growing regional market due to growing demand from payers for data that defines the value and effectiveness of medicines, growing demand in conducting real-world studies in drug R&D, and increasing government interest in using real-world studies for regulatory decision-making.

Key companies operating in the global RWE solutions market are IQVIA Holdings Inc. (U.S.), ICON plc (Ireland), PPD, Inc. (U.S.), SYNEOS HEALTH, INC. (U.S.), CLARIVATE PLC (U.S.), Medpace Holdings Inc. (U.S.), Symphony Innovation, LLC (U.S.), Clinigen Group plc (U.K.), Cognizant Technology Solutions Corporation (U.S.), IBM Corporation (U.S.), Oracle Corporation (U.S.), PAREXEL International Corporation (U.S.), PerkinElmer, Inc. (U.S.), SAS Institute Inc. (U.S.), UnitedHealth Group Incorporated (U.S.), and Flatiron Health (U.S.) among others.

TOP 10 COMPANIES IN REAL WORLD EVIDENCE (RWE)SOLUTIONS MARKET

Scope of the Report

RWE Solutions Market, by Component

• Datasets
  • Disparate Datasets
    • EMR/EHR/Clinical Data
    • Claims & Billing Data
    • Pharmacy Data
    • Product/Disease Registries Data
    • Other Disparate Datasets
  • Integrated Datasets
• Consulting & Analytics

(Note: Other Disparate Datasets include data generated from mobile devices, wearable devices, and social media)

RWE Solutions Market, by Application

• Market Access & Reimbursement/Coverage Decisions
• Drug Development & Approvals
  • Oncology
  • Neurology
  • Immunology
  • Cardiovascular Diseases
  • Other Therapeutic Areas
• Post Market Surveillance
• Medical Device Development & Approvals
• Other Applications

(Note: Other Therapeutic Areas include infectious diseases, musculoskeletal disorders, dermatological diseases, and respiratory diseases, Other Applications include regulatory and clinical decision-making)

RWE Solutions Market, by End User

• Pharmaceutical, Biotechnology, and Medical Device Companies
• Healthcare Payers
• Healthcare Providers
• Other End Users

(Note: Other end users include academic research institutions, patient advocacy groups, regulators, and health technology assessment agencies)

RWE Solutions Market, by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe (RoE)   
• Asia-Pacific (APAC)
  • Japan
  • China
  • India
  • South Korea
  • Taiwan
  • Singapore
  • Rest of APAC (RoAPAC)
• Latin America
• Middle East & Africa

Download Free Sample Report Now @   https://www.meticulousresearch.com/download-sample-report/cp_id=4954?utm_source=Article&utm_medium=Social&utm_campaign=Product&utm_content=15-12-2021

 

Related Reports:

Healthcare IT Market by Product (EMR, mHealth, PHM, RIS, PACS, RCM, Healthcare Analytics, Telehealth, SCM, HIE), Component (Software, Service), Delivery Mode (Web, Cloud) and End User (Hospital, Payer, Pharmacy, Ambulatory, Homecare)—Global Forecast to 2027

 

Engage Your Audience with " Live Streaming “: "Trend, Demand and Technology."

The rising popularity of live streaming technology for better brand engagement and reach to consumers, the surging popularity of e-sports and video games, growing preference for live streaming over social posts, and increasing adoption of smartphones coupled with faster internet are expected to drive the growth of the live streaming market.

Additionally, the growing need to optimize network bandwidth and increase the consumer base for live streaming content further contributes to market growth. Furthermore, the incorporation of advanced technologies in the digital media industry is the new trend in the live streaming market. However, fake traffic on live streaming sites is creating new challenges for the overall market growth. Also, connectivity and production issues may restraint the growth of this market in the approaching years to some extent.

According to a new market research report titled, “Live Streaming Market by Component (Platform, Services), Offering Model (B2B, B2C), Streaming Type (Audio, Video, Game), Vertical (Media & Entertainment, Education, Sports & Gaming, Government, Fitness), and Geography – Global Forecast to 2028,” published by Meticulous Research®, the live streaming market is expected to grow at a CAGR of 22.4% from 2021 to 2028 to reach $4.26 billion by 2028.

Download Research PDF with TOC @ https://www.meticulousresearch.com/download-sample-report/cp_id=5225

Impact of COVID-19 on the Live Streaming Market

The COVID-19 disrupted people’s work lives, fueling significant growth in people seeking live streaming, particularly in emerging markets. The pandemic transformed live video technology into nothing short of a necessity. Healthcare, business continuity, public safety, and mental health all now depend on it. During the pandemic, live streaming was used as a workaround to isolation measures in various ways. Religious services, virtual events, and statewide town halls were all broadcasted over the Internet due to widespread stay-at-home orders. Many of these are just extensions of traditional broadcasts that benefited from the ease of use of live streaming.

Live streaming platforms, such as Zoom, Skype, Amazon Chime, BlueJeans, and Cisco WebEx, were popular in business settings. Google Hangouts, Facetime, and Houseparty were also common for personal communications during this pandemic.

But, safety concerns have hit the news cycle. Incidents of ‘Zoombombing,’ during which unintended attendees join private meetings, have revealed why many enterprises choose to deploy streaming infrastructure in-house. Moreover, AI added value to video apps with voice-to-text transcription, natural language processing, and balanced sound and computer vision.

Several organizations that leveraged streaming technology for telemedicine proved instrumental in efforts to flatten the COVID-19 curve. Virtual doctor visits finally went mainstream, while live video sharing tools helped contain the spread. Another company that utilized telemedicine technology to ease the burden of social distancing was AngelEye Health. The clinical communication platform allowed families to watch their newborn baby while being cared for in the neonatal intensive care unit (NICU).

Several organizations focused on digital technologies to build a brand and showcase new services and products for producing low-cost hardware aimed at the broadcaster with live streaming at the forefront. For instance, in 2021, Innovative Systems, Inc. (U.S.) partnered with Midwest Video Solutions (U.S.) to deliver a fully hosted end‐to‐end streaming video and headend service. Also, in 2021, FilmMyMatch (U.S.) signed an agreement with JOYMO (Norway) to deliver live streaming, video management, and production services to clients across the U.K.

Quick Buy – Live Streaming Market Research Report: https://www.meticulousresearch.com/BuyNowToCheckout/1592

Live Streaming Market Overview

The overall live streaming market is segmented on the basis of component [(platform, services (subscription services, advertisement, and video production & content creation services)], offering model (business-to-business and business-to-consumer), streaming type (audio streaming, video streaming, and game streaming), vertical (enterprises, media & entertainment, education & e-learning industry, sports & gaming industry, government, fitness industry, religious organizations, and others), and geography. The study also evaluates industry competitors and analyses the market at the country and region levels.

Based on component, the services segment is estimated to account for the largest share of the overall live streaming market in 2021. The large share of this segment is primarily driven by the growing demand for new installation and integration of live-streaming platforms; the need for professional post-production support, up-gradation, and maintenance to help deliver content based on client specifications and provide a personalized experience to viewers; and surging demand for customer support, content creation services, and subscription services.

Based on offering model, the business-to-consumer segment is estimated to account for the largest share of the overall live streaming market in 2021. The large share of this segment is primarily driven by the rising adoption of smart devices coupled with faster internet penetration, increasing need for transmission of live content on the Internet for better brand engagement, and a surging number of social media platforms & s-commerce sites.

Based on streaming type, the video streaming segment is estimated to account for the largest share of the overall live streaming market in 2021. The large share of this segment is primarily driven by the growing use of influencers to drive new applications and attract new customers for branding and marketing, growing adoption of cloud-based solutions to increase the reach of live video content, and rising customer online data consumption and surfing behavior. However, the game streaming segment is slated to grow at the highest CAGR during the forecast period.

Based on vertical, the media & entertainment sector is estimated to account for the largest share of the overall live streaming market in 2021. The large share of this segment is primarily driven by the growing popularity of online live video streaming, rising technological advancements, increasing consumer base for live streaming content, growing adoption of cloud-based video streaming solutions, and use of AI for increasing the reach of video content.

Based on geography, the Asia-Pacific region is estimated to account for the largest share of the overall live streaming market in 2021. The large share of this region is primarily attributed to the presence of major live streaming players along with several emerging startups in the region, surging adoption of live-streaming platforms for better brand engagement, increasing consumer base for the live streaming, and rising focus on digitalization with technological advancement in cloud computing, AI, and 5G.

The report also includes an extensive assessment of key strategies adopted by leading market participants over the past four years. The live streaming market witnessed a surge in the number of partnerships & agreements in recent years, enabling companies to broaden their product portfolios in live streaming. For instance, in 2021, Tiktok (U.S.) partnered with UFC (U.S.) to deliver exclusive live-stream content on its platform. In 2021, Scienjoy Holding Corporation (China) partnered with the Global Friendship Exchange Foundation to establish a live streaming studio and non-fungible token (NFT) art gallery in New York.

The global live streaming market is fragmented in nature. The major players operating in this market are Flux Broadcast (U.K.), Facebook Inc. (Instagram) (U.S.), Dacast (U.S.), Twitch Interactive, Inc. (U.S.), IBM Corporation (U.S.), Huya Inc. (China), Stream Hatchet SLU (Spain), Empire Video Productions, LLC (Florida), Afreecatv Corp. (South Korea), Streamshark (Australia), Dailymotion (France), Vimeo, Inc. (U.S.), Tiktok (U.S.), EventStreaming.TV (WaveFX Ltd.) (U.K.), Pluto Inc. (U.S.), Boxcast (U.S.), VosCast (U.S.), Uplynk (U.S.), and Wowza (U.S.), among others.

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/live-streaming-market-5225?utm_source=Blog&utm_medium=Social&utm_campaign=Product&utm_content=15-12-2021

Scope of the Report:

Live Streaming Market, by Component         

• Platforms
• Services
• Video Production and Content Creation Services
• Subscription Services
• Advertisement

Live Streaming Market, by Offering Model              

• Business-to-Business (B2B)
• Business-to-Consumer (B2C)

Live Streaming Market, by Streaming Type            

• Audio Streaming
• Video Streaming
• Game Streaming

Live Streaming Market, by Vertical               

• Enterprises
• Media & Entertainment
• Education & E-learning Industry
• Sports & Game Industry
• Government
• Fitness Industry
• Religious Organizations
• Others

Live Streaming Market, by Geography

• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Switzerland
• Sweden
• Rest of Europe
• Asia-Pacific
• Japan
• China
• India
• South Korea
• Australia & New Zealand
• Indonesia
• Thailand
• Rest of Asia-Pacific
• Latin America
• Mexico
• Brazil
• Rest of Latin America
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Israel
• Rest of the Middle East & Africa

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5225?utm_source=Blog&utm_medium=Social&utm_campaign=Product&utm_content=15-12-2021

 

Related Reports:             

Video Conferencing Market by Technology (VaaS, USB-VC, Room-based Codec System), Component, Deployment Mode, Organization Size, End-User (Education, IT & Comm., Healthcare, BFSI, Oil & Gas, Legal, Media)—Global Forecast to 2028

Digital Transformation Market by Technology (IoT, Cloud Computing, Big Data Analytics, Artificial Intelligence, Cybersecurity, Mobility Solutions, AR/VR, Robotic Process Automation, Others), End-use Industry, Industry Size, Process - Global Forecast to 2025